MX2024007863A - Uso de compuestos de aminopirazol. - Google Patents

Uso de compuestos de aminopirazol.

Info

Publication number
MX2024007863A
MX2024007863A MX2024007863A MX2024007863A MX2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A MX 2024007863 A MX2024007863 A MX 2024007863A
Authority
MX
Mexico
Prior art keywords
compounds
aminopyrazole compounds
jak
aminopyrazole
atopic
Prior art date
Application number
MX2024007863A
Other languages
English (en)
Spanish (es)
Inventor
Linda Horspool
Timothy Kowalski
Christina Möller
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2024007863A publication Critical patent/MX2024007863A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2024007863A 2021-12-24 2022-12-23 Uso de compuestos de aminopirazol. MX2024007863A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21217736 2021-12-24
PCT/EP2022/087698 WO2023118555A1 (en) 2021-12-24 2022-12-23 Use of aminopyrazole compounds

Publications (1)

Publication Number Publication Date
MX2024007863A true MX2024007863A (es) 2024-08-30

Family

ID=79025165

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024007863A MX2024007863A (es) 2021-12-24 2022-12-23 Uso de compuestos de aminopirazol.

Country Status (9)

Country Link
US (1) US20250049775A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452970A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024545293A (cg-RX-API-DMAC7.html)
KR (1) KR20240124925A (cg-RX-API-DMAC7.html)
CN (1) CN118541364A (cg-RX-API-DMAC7.html)
AU (1) AU2022418280A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242449A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024007863A (cg-RX-API-DMAC7.html)
WO (1) WO2023118555A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3951899A (en) 1998-06-19 2000-01-05 Pfizer Products Inc. Pyrrolo(2,3-d)pyrimidine compounds
RS53382B (sr) 2008-08-20 2014-10-31 Zoetis Llc Jedinjenja pirol [2,3-d]pirimidina
AU2012312303B2 (en) 2011-09-22 2016-09-15 Merck Sharp & Dohme Corp. Cyanomethylpyrazole carboxamides as janus kinase inhibitors
WO2014146246A1 (en) 2013-03-19 2014-09-25 Merck Sharp & Dohme Corp. Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
AU2017376398B2 (en) 2016-12-14 2021-07-15 Intervet International B.V. Aminopyrazoles as selective janus kinase inhibitors
KR20220119024A (ko) * 2019-12-20 2022-08-26 인터벳 인터내셔널 비.브이. 피라졸 제약 조성물

Also Published As

Publication number Publication date
CA3242449A1 (en) 2023-06-29
KR20240124925A (ko) 2024-08-19
JP2024545293A (ja) 2024-12-05
US20250049775A1 (en) 2025-02-13
CN118541364A (zh) 2024-08-23
AU2022418280A1 (en) 2024-06-13
WO2023118555A1 (en) 2023-06-29
EP4452970A1 (en) 2024-10-30

Similar Documents

Publication Publication Date Title
CO2022002413A2 (es) Composiciones y métodos para tratar la psoriasis y la dermatitis atópica usando prevotella histicola
DOP2018000226A (es) Nuevos derivados de pirazolopirimidina
CL2019002255A1 (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas.
ECSP19052302A (es) Derivados de benzooxazol como inmunomoduladores
CO2018007528A2 (es) Compuestos heterocíclicos como inmunomoduladores
CO2019000386A2 (es) Compuestos heterocíclicos como inmunomoduladores
MX2019005009A (es) 1,2,4-triazolonas 2,4,5-trisustituidas.
MX390535B (es) Compuestos de amino-triazolopiridina y su uso en el trataniento del cancer.
ECSP18083519A (es) Inhibidores de bromodominios
ECSP14013148A (es) Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
ECSP18012103A (es) Inhibidores del receptor del factor estimulador de colonias 1 (csf-1r)
CR20150633A (es) Derivados del bipirazol como inhibidores jak
CL2018001569A1 (es) Compuestos heteroaromáticos como inhibidores de btk
CL2019000476A1 (es) Compuestos de heteroarilcarboxamida como inhibidores de ripk2.
CU24608B1 (es) Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas y métodos para preparar dichos compuestos
DOP2019000169A (es) Pirazolo[3,4-b]piridinas e imidazo[1,5-b]piridazinas como inhibidores de pde1
CL2021001244A1 (es) Compuestos antibióticos, métodos de fabricación de los mismos, composiciones farmacéuticas conteniendo los mismos y usos de los mismos
CL2023000892A1 (es) Composiciones terapéuticas y métodos para el tratamiento de la hepatitis b (divisional).
CL2019001091A1 (es) Tratamientos de combinación que comprenden la administración de imidazopirazinonas.
CL2020001107A1 (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3.
NI201801172A (es) Nuevos compuestos para el tratamiento de enfermedades parasitarias
CO2026005573A2 (es) Compuestos heterobifuncionales y métodos de tratamiento de enfermedades
CO2020001506A2 (es) Nuevos compuestos
MX2022016179A (es) Compuestos y metodos para tratar infecciones fungicas.
CA3242449A1 (en) Use of aminopyrazole compounds